nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenelzine—CYP2E1—Dacarbazine—sarcoma	0.13	0.175	CbGbCtD
Phenelzine—CYP2E1—Mitoxantrone—sarcoma	0.101	0.136	CbGbCtD
Phenelzine—CYP3A7-CYP3A51P—Vincristine—sarcoma	0.0718	0.0966	CbGbCtD
Phenelzine—CYP3A7—Vincristine—sarcoma	0.0718	0.0966	CbGbCtD
Phenelzine—CYP3A4—Thiotepa—sarcoma	0.071	0.0955	CbGbCtD
Phenelzine—CYP2E1—Etoposide—sarcoma	0.0635	0.0855	CbGbCtD
Phenelzine—CYP3A5—Vincristine—sarcoma	0.0539	0.0725	CbGbCtD
Phenelzine—CYP3A5—Etoposide—sarcoma	0.0494	0.0664	CbGbCtD
Phenelzine—CYP2C8—Etoposide—sarcoma	0.0475	0.0638	CbGbCtD
Phenelzine—CYP3A4—Mitoxantrone—sarcoma	0.0305	0.0411	CbGbCtD
Phenelzine—CYP3A4—Vincristine—sarcoma	0.021	0.0283	CbGbCtD
Phenelzine—CYP3A4—Etoposide—sarcoma	0.0193	0.0259	CbGbCtD
Phenelzine—CYP3A4—Doxorubicin—sarcoma	0.0131	0.0177	CbGbCtD
Phenelzine—AOC3—endothelium—sarcoma	0.00732	0.0477	CbGeAlD
Phenelzine—GPT2—mammary gland—sarcoma	0.00679	0.0442	CbGeAlD
Phenelzine—AOC3—mammary gland—sarcoma	0.0059	0.0384	CbGeAlD
Phenelzine—GPT—seminal vesicle—sarcoma	0.00569	0.0371	CbGeAlD
Phenelzine—ABAT—mammary gland—sarcoma	0.00498	0.0325	CbGeAlD
Phenelzine—GPT2—seminal vesicle—sarcoma	0.00435	0.0284	CbGeAlD
Phenelzine—AOC3—myometrium—sarcoma	0.00418	0.0273	CbGeAlD
Phenelzine—GPT2—connective tissue—sarcoma	0.00398	0.026	CbGeAlD
Phenelzine—AOC3—seminal vesicle—sarcoma	0.00378	0.0246	CbGeAlD
Phenelzine—AOC3—hematopoietic system—sarcoma	0.00359	0.0234	CbGeAlD
Phenelzine—GPT—tendon—sarcoma	0.00358	0.0233	CbGeAlD
Phenelzine—CYP3A43—testis—sarcoma	0.00352	0.0229	CbGeAlD
Phenelzine—GPT—bone marrow—sarcoma	0.00347	0.0226	CbGeAlD
Phenelzine—AOC3—connective tissue—sarcoma	0.00346	0.0225	CbGeAlD
Phenelzine—CYP3A43—liver—sarcoma	0.00333	0.0217	CbGeAlD
Phenelzine—Metabolic acidosis—Etoposide—sarcoma	0.00332	0.0323	CcSEcCtD
Phenelzine—AOC3—smooth muscle tissue—sarcoma	0.00316	0.0206	CbGeAlD
Phenelzine—GPT2—cardiac atrium—sarcoma	0.00314	0.0205	CbGeAlD
Phenelzine—GPT—testis—sarcoma	0.00296	0.0193	CbGeAlD
Phenelzine—GPT—liver—sarcoma	0.0028	0.0183	CbGeAlD
Phenelzine—GPT2—tendon—sarcoma	0.00274	0.0178	CbGeAlD
Phenelzine—AOC3—cardiac atrium—sarcoma	0.00273	0.0178	CbGeAlD
Phenelzine—AOC3—uterus—sarcoma	0.00271	0.0177	CbGeAlD
Phenelzine—AOC3—lymphoid tissue—sarcoma	0.00253	0.0165	CbGeAlD
Phenelzine—AOC3—tendon—sarcoma	0.00238	0.0155	CbGeAlD
Phenelzine—AOC3—bone marrow—sarcoma	0.0023	0.015	CbGeAlD
Phenelzine—Nystagmus—Vincristine—sarcoma	0.00227	0.022	CcSEcCtD
Phenelzine—GPT2—testis—sarcoma	0.00227	0.0148	CbGeAlD
Phenelzine—GPT2—liver—sarcoma	0.00214	0.014	CbGeAlD
Phenelzine—Delirium—Thiotepa—sarcoma	0.00213	0.0206	CcSEcCtD
Phenelzine—ABAT—tendon—sarcoma	0.00201	0.0131	CbGeAlD
Phenelzine—AOC3—testis—sarcoma	0.00197	0.0128	CbGeAlD
Phenelzine—AOC3—liver—sarcoma	0.00186	0.0121	CbGeAlD
Phenelzine—CYP2C8—mammary gland—sarcoma	0.00184	0.012	CbGeAlD
Phenelzine—MAOB—myometrium—sarcoma	0.00172	0.0112	CbGeAlD
Phenelzine—ABAT—testis—sarcoma	0.00166	0.0108	CbGeAlD
Phenelzine—MAOB—embryo—sarcoma	0.00166	0.0108	CbGeAlD
Phenelzine—GPT2—lymph node—sarcoma	0.00164	0.0107	CbGeAlD
Phenelzine—ABAT—liver—sarcoma	0.00157	0.0102	CbGeAlD
Phenelzine—MAOB—seminal vesicle—sarcoma	0.00155	0.0101	CbGeAlD
Phenelzine—CYP3A7—liver—sarcoma	0.00149	0.00973	CbGeAlD
Phenelzine—Coma—Vincristine—sarcoma	0.00148	0.0144	CcSEcCtD
Phenelzine—MAOB—hematopoietic system—sarcoma	0.00148	0.00963	CbGeAlD
Phenelzine—MAOA—myometrium—sarcoma	0.00147	0.00957	CbGeAlD
Phenelzine—AOC3—lymph node—sarcoma	0.00143	0.0093	CbGeAlD
Phenelzine—MAOB—connective tissue—sarcoma	0.00142	0.00927	CbGeAlD
Phenelzine—MAOA—embryo—sarcoma	0.00141	0.0092	CbGeAlD
Phenelzine—Hypernatraemia—Epirubicin—sarcoma	0.0014	0.0136	CcSEcCtD
Phenelzine—MAOA—seminal vesicle—sarcoma	0.00133	0.00864	CbGeAlD
Phenelzine—Hypernatraemia—Doxorubicin—sarcoma	0.0013	0.0126	CcSEcCtD
Phenelzine—CYP2C19—hematopoietic system—sarcoma	0.00129	0.00839	CbGeAlD
Phenelzine—CYP3A7-CYP3A51P—liver—sarcoma	0.00127	0.00827	CbGeAlD
Phenelzine—Urinary retention—Thiotepa—sarcoma	0.00126	0.0123	CcSEcCtD
Phenelzine—MAOA—hematopoietic system—sarcoma	0.00126	0.00822	CbGeAlD
Phenelzine—Ataxia—Thiotepa—sarcoma	0.00125	0.0121	CcSEcCtD
Phenelzine—MAOA—connective tissue—sarcoma	0.00121	0.00791	CbGeAlD
Phenelzine—ABAT—lymph node—sarcoma	0.00121	0.00786	CbGeAlD
Phenelzine—CYP2C8—hematopoietic system—sarcoma	0.00112	0.00732	CbGeAlD
Phenelzine—MAOB—cardiac atrium—sarcoma	0.00112	0.00731	CbGeAlD
Phenelzine—Urinary retention—Vincristine—sarcoma	0.00112	0.0109	CcSEcCtD
Phenelzine—MAOB—uterus—sarcoma	0.00112	0.00727	CbGeAlD
Phenelzine—Ataxia—Vincristine—sarcoma	0.00111	0.0107	CcSEcCtD
Phenelzine—Weight increased—Thiotepa—sarcoma	0.00104	0.0101	CcSEcCtD
Phenelzine—Nystagmus—Epirubicin—sarcoma	0.00103	0.01	CcSEcCtD
Phenelzine—CYP3A5—hematopoietic system—sarcoma	0.00101	0.00661	CbGeAlD
Phenelzine—Jaundice—Thiotepa—sarcoma	0.000997	0.00968	CcSEcCtD
Phenelzine—CYP2E1—seminal vesicle—sarcoma	0.000996	0.00649	CbGeAlD
Phenelzine—MAOB—tendon—sarcoma	0.000978	0.00637	CbGeAlD
Phenelzine—MAOA—cardiac atrium—sarcoma	0.000957	0.00624	CbGeAlD
Phenelzine—Nystagmus—Doxorubicin—sarcoma	0.000954	0.00926	CcSEcCtD
Phenelzine—MAOA—uterus—sarcoma	0.000952	0.00621	CbGeAlD
Phenelzine—CYP2E1—hematopoietic system—sarcoma	0.000946	0.00617	CbGeAlD
Phenelzine—Erectile dysfunction—Vincristine—sarcoma	0.000937	0.0091	CcSEcCtD
Phenelzine—Erectile dysfunction—Mitoxantrone—sarcoma	0.000913	0.00886	CcSEcCtD
Phenelzine—Weight increased—Mitoxantrone—sarcoma	0.000902	0.00876	CcSEcCtD
Phenelzine—Drowsiness—Mitoxantrone—sarcoma	0.000884	0.00858	CcSEcCtD
Phenelzine—Liver injury—Epirubicin—sarcoma	0.000875	0.0085	CcSEcCtD
Phenelzine—Sweating—Vincristine—sarcoma	0.00087	0.00844	CcSEcCtD
Phenelzine—Jaundice—Mitoxantrone—sarcoma	0.000861	0.00836	CcSEcCtD
Phenelzine—Delirium—Epirubicin—sarcoma	0.000856	0.00831	CcSEcCtD
Phenelzine—Sweating—Mitoxantrone—sarcoma	0.000847	0.00822	CcSEcCtD
Phenelzine—MAOA—tendon—sarcoma	0.000834	0.00544	CbGeAlD
Phenelzine—Liver injury—Doxorubicin—sarcoma	0.00081	0.00786	CcSEcCtD
Phenelzine—MAOB—testis—sarcoma	0.00081	0.00528	CbGeAlD
Phenelzine—Delirium—Doxorubicin—sarcoma	0.000792	0.00769	CcSEcCtD
Phenelzine—Nervousness—Thiotepa—sarcoma	0.000777	0.00754	CcSEcCtD
Phenelzine—MAOB—liver—sarcoma	0.000766	0.00499	CbGeAlD
Phenelzine—CYP3A4—hematopoietic system—sarcoma	0.000761	0.00496	CbGeAlD
Phenelzine—Vision blurred—Thiotepa—sarcoma	0.000754	0.00732	CcSEcCtD
Phenelzine—Hepatocellular injury—Epirubicin—sarcoma	0.000736	0.00715	CcSEcCtD
Phenelzine—Ill-defined disorder—Dactinomycin—sarcoma	0.000736	0.00715	CcSEcCtD
Phenelzine—Agitation—Thiotepa—sarcoma	0.000735	0.00713	CcSEcCtD
Phenelzine—Jaundice—Etoposide—sarcoma	0.000716	0.00695	CcSEcCtD
Phenelzine—Leukopenia—Thiotepa—sarcoma	0.000716	0.00695	CcSEcCtD
Phenelzine—Malaise—Dactinomycin—sarcoma	0.000716	0.00695	CcSEcCtD
Phenelzine—Leukopenia—Dactinomycin—sarcoma	0.00071	0.0069	CcSEcCtD
Phenelzine—Convulsion—Thiotepa—sarcoma	0.000693	0.00673	CcSEcCtD
Phenelzine—MAOA—testis—sarcoma	0.000691	0.0045	CbGeAlD
Phenelzine—Hepatocellular injury—Doxorubicin—sarcoma	0.000681	0.00662	CcSEcCtD
Phenelzine—Anxiety—Thiotepa—sarcoma	0.000678	0.00659	CcSEcCtD
Phenelzine—Coma—Epirubicin—sarcoma	0.000673	0.00653	CcSEcCtD
Phenelzine—Discomfort—Dactinomycin—sarcoma	0.000667	0.00648	CcSEcCtD
Phenelzine—CYP2C19—liver—sarcoma	0.000667	0.00435	CbGeAlD
Phenelzine—CYP2E1—lymphoid tissue—sarcoma	0.000666	0.00434	CbGeAlD
Phenelzine—MAOA—liver—sarcoma	0.000653	0.00426	CbGeAlD
Phenelzine—Agitation—Vincristine—sarcoma	0.000652	0.00633	CcSEcCtD
Phenelzine—Vision blurred—Mitoxantrone—sarcoma	0.000651	0.00632	CcSEcCtD
Phenelzine—Oedema—Dactinomycin—sarcoma	0.000648	0.00629	CcSEcCtD
Phenelzine—Hypertonia—Epirubicin—sarcoma	0.000646	0.00627	CcSEcCtD
Phenelzine—Ill-defined disorder—Mitoxantrone—sarcoma	0.000641	0.00622	CcSEcCtD
Phenelzine—Tachycardia—Thiotepa—sarcoma	0.000637	0.00618	CcSEcCtD
Phenelzine—Leukopenia—Vincristine—sarcoma	0.000635	0.00616	CcSEcCtD
Phenelzine—CYP2E1—tendon—sarcoma	0.000626	0.00408	CbGeAlD
Phenelzine—Malaise—Mitoxantrone—sarcoma	0.000623	0.00604	CcSEcCtD
Phenelzine—Coma—Doxorubicin—sarcoma	0.000623	0.00604	CcSEcCtD
Phenelzine—Leukopenia—Mitoxantrone—sarcoma	0.000618	0.006	CcSEcCtD
Phenelzine—CYP2C8—testis—sarcoma	0.000616	0.00401	CbGeAlD
Phenelzine—Convulsion—Vincristine—sarcoma	0.000614	0.00596	CcSEcCtD
Phenelzine—Convulsion—Mitoxantrone—sarcoma	0.000598	0.00581	CcSEcCtD
Phenelzine—Hypertonia—Doxorubicin—sarcoma	0.000597	0.0058	CcSEcCtD
Phenelzine—MAOB—lymph node—sarcoma	0.000587	0.00382	CbGeAlD
Phenelzine—Paraesthesia—Thiotepa—sarcoma	0.000586	0.00569	CcSEcCtD
Phenelzine—Anxiety—Mitoxantrone—sarcoma	0.000586	0.00569	CcSEcCtD
Phenelzine—CYP2C8—liver—sarcoma	0.000582	0.00379	CbGeAlD
Phenelzine—Discomfort—Mitoxantrone—sarcoma	0.000581	0.00564	CcSEcCtD
Phenelzine—Somnolence—Thiotepa—sarcoma	0.00058	0.00563	CcSEcCtD
Phenelzine—Oedema—Vincristine—sarcoma	0.000579	0.00562	CcSEcCtD
Phenelzine—Dyspepsia—Thiotepa—sarcoma	0.000574	0.00558	CcSEcCtD
Phenelzine—Oedema—Mitoxantrone—sarcoma	0.000564	0.00547	CcSEcCtD
Phenelzine—Gastrointestinal disorder—Thiotepa—sarcoma	0.000563	0.00547	CcSEcCtD
Phenelzine—Fatigue—Thiotepa—sarcoma	0.000563	0.00546	CcSEcCtD
Phenelzine—Hyperhidrosis—Vincristine—sarcoma	0.000559	0.00543	CcSEcCtD
Phenelzine—Fatigue—Dactinomycin—sarcoma	0.000558	0.00542	CcSEcCtD
Phenelzine—Constipation—Thiotepa—sarcoma	0.000558	0.00542	CcSEcCtD
Phenelzine—Shock—Mitoxantrone—sarcoma	0.000554	0.00538	CcSEcCtD
Phenelzine—Tachycardia—Mitoxantrone—sarcoma	0.00055	0.00534	CcSEcCtD
Phenelzine—Hyperhidrosis—Mitoxantrone—sarcoma	0.000545	0.00529	CcSEcCtD
Phenelzine—Feeling abnormal—Thiotepa—sarcoma	0.000538	0.00522	CcSEcCtD
Phenelzine—Feeling abnormal—Dactinomycin—sarcoma	0.000534	0.00518	CcSEcCtD
Phenelzine—Ill-defined disorder—Etoposide—sarcoma	0.000533	0.00517	CcSEcCtD
Phenelzine—CYP3A5—liver—sarcoma	0.000526	0.00343	CbGeAlD
Phenelzine—Insomnia—Vincristine—sarcoma	0.000523	0.00508	CcSEcCtD
Phenelzine—Paraesthesia—Vincristine—sarcoma	0.00052	0.00504	CcSEcCtD
Phenelzine—CYP2E1—testis—sarcoma	0.000519	0.00338	CbGeAlD
Phenelzine—Malaise—Etoposide—sarcoma	0.000518	0.00503	CcSEcCtD
Phenelzine—Body temperature increased—Thiotepa—sarcoma	0.000516	0.00501	CcSEcCtD
Phenelzine—Leukopenia—Etoposide—sarcoma	0.000514	0.00499	CcSEcCtD
Phenelzine—Body temperature increased—Dactinomycin—sarcoma	0.000512	0.00497	CcSEcCtD
Phenelzine—Paraesthesia—Mitoxantrone—sarcoma	0.000506	0.00491	CcSEcCtD
Phenelzine—Ataxia—Epirubicin—sarcoma	0.000503	0.00488	CcSEcCtD
Phenelzine—Somnolence—Mitoxantrone—sarcoma	0.000501	0.00486	CcSEcCtD
Phenelzine—MAOA—lymph node—sarcoma	0.000501	0.00326	CbGeAlD
Phenelzine—Gastrointestinal disorder—Vincristine—sarcoma	0.0005	0.00485	CcSEcCtD
Phenelzine—Fatigue—Vincristine—sarcoma	0.000499	0.00484	CcSEcCtD
Phenelzine—Convulsion—Etoposide—sarcoma	0.000498	0.00483	CcSEcCtD
Phenelzine—Dyspepsia—Mitoxantrone—sarcoma	0.000496	0.00482	CcSEcCtD
Phenelzine—Constipation—Vincristine—sarcoma	0.000495	0.0048	CcSEcCtD
Phenelzine—CYP2E1—liver—sarcoma	0.00049	0.00319	CbGeAlD
Phenelzine—Orthostatic hypotension—Epirubicin—sarcoma	0.000488	0.00474	CcSEcCtD
Phenelzine—Fatigue—Mitoxantrone—sarcoma	0.000486	0.00472	CcSEcCtD
Phenelzine—Discomfort—Etoposide—sarcoma	0.000483	0.00469	CcSEcCtD
Phenelzine—Constipation—Mitoxantrone—sarcoma	0.000482	0.00468	CcSEcCtD
Phenelzine—Asthenia—Thiotepa—sarcoma	0.000468	0.00455	CcSEcCtD
Phenelzine—Ataxia—Doxorubicin—sarcoma	0.000465	0.00452	CcSEcCtD
Phenelzine—Asthenia—Dactinomycin—sarcoma	0.000465	0.00451	CcSEcCtD
Phenelzine—Feeling abnormal—Mitoxantrone—sarcoma	0.000464	0.00451	CcSEcCtD
Phenelzine—Pruritus—Thiotepa—sarcoma	0.000462	0.00448	CcSEcCtD
Phenelzine—Tachycardia—Etoposide—sarcoma	0.000457	0.00444	CcSEcCtD
Phenelzine—Body temperature increased—Vincristine—sarcoma	0.000457	0.00444	CcSEcCtD
Phenelzine—Hyperhidrosis—Etoposide—sarcoma	0.000453	0.0044	CcSEcCtD
Phenelzine—Orthostatic hypotension—Doxorubicin—sarcoma	0.000452	0.00439	CcSEcCtD
Phenelzine—Body temperature increased—Mitoxantrone—sarcoma	0.000445	0.00432	CcSEcCtD
Phenelzine—Dizziness—Thiotepa—sarcoma	0.000432	0.00419	CcSEcCtD
Phenelzine—Paraesthesia—Etoposide—sarcoma	0.000421	0.00409	CcSEcCtD
Phenelzine—Weight increased—Epirubicin—sarcoma	0.00042	0.00408	CcSEcCtD
Phenelzine—Somnolence—Etoposide—sarcoma	0.000417	0.00405	CcSEcCtD
Phenelzine—Asthenia—Vincristine—sarcoma	0.000415	0.00403	CcSEcCtD
Phenelzine—Vomiting—Thiotepa—sarcoma	0.000415	0.00403	CcSEcCtD
Phenelzine—Drowsiness—Epirubicin—sarcoma	0.000412	0.004	CcSEcCtD
Phenelzine—Vomiting—Dactinomycin—sarcoma	0.000412	0.004	CcSEcCtD
Phenelzine—Rash—Thiotepa—sarcoma	0.000411	0.00399	CcSEcCtD
Phenelzine—Dermatitis—Thiotepa—sarcoma	0.000411	0.00399	CcSEcCtD
Phenelzine—Headache—Thiotepa—sarcoma	0.000409	0.00397	CcSEcCtD
Phenelzine—Rash—Dactinomycin—sarcoma	0.000408	0.00396	CcSEcCtD
Phenelzine—Gastrointestinal disorder—Etoposide—sarcoma	0.000405	0.00393	CcSEcCtD
Phenelzine—Asthenia—Mitoxantrone—sarcoma	0.000404	0.00393	CcSEcCtD
Phenelzine—Fatigue—Etoposide—sarcoma	0.000404	0.00392	CcSEcCtD
Phenelzine—Jaundice—Epirubicin—sarcoma	0.000402	0.0039	CcSEcCtD
Phenelzine—Constipation—Etoposide—sarcoma	0.000401	0.00389	CcSEcCtD
Phenelzine—Sweating—Epirubicin—sarcoma	0.000395	0.00383	CcSEcCtD
Phenelzine—CYP3A4—liver—sarcoma	0.000394	0.00257	CbGeAlD
Phenelzine—Weight increased—Doxorubicin—sarcoma	0.000389	0.00378	CcSEcCtD
Phenelzine—Nausea—Thiotepa—sarcoma	0.000388	0.00376	CcSEcCtD
Phenelzine—Feeling abnormal—Etoposide—sarcoma	0.000386	0.00375	CcSEcCtD
Phenelzine—Nausea—Dactinomycin—sarcoma	0.000385	0.00373	CcSEcCtD
Phenelzine—Dizziness—Vincristine—sarcoma	0.000383	0.00371	CcSEcCtD
Phenelzine—Drowsiness—Doxorubicin—sarcoma	0.000381	0.0037	CcSEcCtD
Phenelzine—Jaundice—Doxorubicin—sarcoma	0.000372	0.00361	CcSEcCtD
Phenelzine—Body temperature increased—Etoposide—sarcoma	0.000371	0.0036	CcSEcCtD
Phenelzine—Vomiting—Vincristine—sarcoma	0.000368	0.00357	CcSEcCtD
Phenelzine—Sweating—Doxorubicin—sarcoma	0.000365	0.00355	CcSEcCtD
Phenelzine—Rash—Vincristine—sarcoma	0.000365	0.00354	CcSEcCtD
Phenelzine—Dermatitis—Vincristine—sarcoma	0.000365	0.00354	CcSEcCtD
Phenelzine—Headache—Vincristine—sarcoma	0.000362	0.00352	CcSEcCtD
Phenelzine—Vomiting—Mitoxantrone—sarcoma	0.000358	0.00348	CcSEcCtD
Phenelzine—Rash—Mitoxantrone—sarcoma	0.000355	0.00345	CcSEcCtD
Phenelzine—Dermatitis—Mitoxantrone—sarcoma	0.000355	0.00345	CcSEcCtD
Phenelzine—Headache—Mitoxantrone—sarcoma	0.000353	0.00343	CcSEcCtD
Phenelzine—Nausea—Vincristine—sarcoma	0.000344	0.00334	CcSEcCtD
Phenelzine—Asthenia—Etoposide—sarcoma	0.000336	0.00326	CcSEcCtD
Phenelzine—Nausea—Mitoxantrone—sarcoma	0.000335	0.00325	CcSEcCtD
Phenelzine—Pruritus—Etoposide—sarcoma	0.000332	0.00322	CcSEcCtD
Phenelzine—Nervousness—Epirubicin—sarcoma	0.000313	0.00304	CcSEcCtD
Phenelzine—Dizziness—Etoposide—sarcoma	0.00031	0.00301	CcSEcCtD
Phenelzine—Vision blurred—Epirubicin—sarcoma	0.000303	0.00295	CcSEcCtD
Phenelzine—Ill-defined disorder—Epirubicin—sarcoma	0.000299	0.0029	CcSEcCtD
Phenelzine—Vomiting—Etoposide—sarcoma	0.000298	0.00289	CcSEcCtD
Phenelzine—Agitation—Epirubicin—sarcoma	0.000296	0.00287	CcSEcCtD
Phenelzine—Rash—Etoposide—sarcoma	0.000296	0.00287	CcSEcCtD
Phenelzine—Dermatitis—Etoposide—sarcoma	0.000295	0.00287	CcSEcCtD
Phenelzine—Headache—Etoposide—sarcoma	0.000294	0.00285	CcSEcCtD
Phenelzine—Malaise—Epirubicin—sarcoma	0.00029	0.00282	CcSEcCtD
Phenelzine—Nervousness—Doxorubicin—sarcoma	0.000289	0.00281	CcSEcCtD
Phenelzine—Leukopenia—Epirubicin—sarcoma	0.000288	0.0028	CcSEcCtD
Phenelzine—Vision blurred—Doxorubicin—sarcoma	0.000281	0.00273	CcSEcCtD
Phenelzine—Convulsion—Epirubicin—sarcoma	0.000279	0.00271	CcSEcCtD
Phenelzine—Nausea—Etoposide—sarcoma	0.000278	0.0027	CcSEcCtD
Phenelzine—Ill-defined disorder—Doxorubicin—sarcoma	0.000276	0.00268	CcSEcCtD
Phenelzine—Agitation—Doxorubicin—sarcoma	0.000274	0.00266	CcSEcCtD
Phenelzine—Anxiety—Epirubicin—sarcoma	0.000273	0.00265	CcSEcCtD
Phenelzine—Discomfort—Epirubicin—sarcoma	0.000271	0.00263	CcSEcCtD
Phenelzine—Malaise—Doxorubicin—sarcoma	0.000269	0.00261	CcSEcCtD
Phenelzine—Dry mouth—Epirubicin—sarcoma	0.000268	0.0026	CcSEcCtD
Phenelzine—Leukopenia—Doxorubicin—sarcoma	0.000267	0.00259	CcSEcCtD
Phenelzine—Oedema—Epirubicin—sarcoma	0.000263	0.00255	CcSEcCtD
Phenelzine—Shock—Epirubicin—sarcoma	0.000259	0.00251	CcSEcCtD
Phenelzine—Convulsion—Doxorubicin—sarcoma	0.000258	0.00251	CcSEcCtD
Phenelzine—Tachycardia—Epirubicin—sarcoma	0.000256	0.00249	CcSEcCtD
Phenelzine—Hyperhidrosis—Epirubicin—sarcoma	0.000254	0.00247	CcSEcCtD
Phenelzine—Anxiety—Doxorubicin—sarcoma	0.000253	0.00245	CcSEcCtD
Phenelzine—Discomfort—Doxorubicin—sarcoma	0.000251	0.00243	CcSEcCtD
Phenelzine—Dry mouth—Doxorubicin—sarcoma	0.000248	0.00241	CcSEcCtD
Phenelzine—Oedema—Doxorubicin—sarcoma	0.000243	0.00236	CcSEcCtD
Phenelzine—Shock—Doxorubicin—sarcoma	0.000239	0.00232	CcSEcCtD
Phenelzine—Insomnia—Epirubicin—sarcoma	0.000238	0.00231	CcSEcCtD
Phenelzine—Tachycardia—Doxorubicin—sarcoma	0.000237	0.0023	CcSEcCtD
Phenelzine—Paraesthesia—Epirubicin—sarcoma	0.000236	0.00229	CcSEcCtD
Phenelzine—Hyperhidrosis—Doxorubicin—sarcoma	0.000235	0.00228	CcSEcCtD
Phenelzine—Somnolence—Epirubicin—sarcoma	0.000234	0.00227	CcSEcCtD
Phenelzine—Dyspepsia—Epirubicin—sarcoma	0.000231	0.00225	CcSEcCtD
Phenelzine—Gastrointestinal disorder—Epirubicin—sarcoma	0.000227	0.0022	CcSEcCtD
Phenelzine—Fatigue—Epirubicin—sarcoma	0.000227	0.0022	CcSEcCtD
Phenelzine—Constipation—Epirubicin—sarcoma	0.000225	0.00218	CcSEcCtD
Phenelzine—Insomnia—Doxorubicin—sarcoma	0.00022	0.00213	CcSEcCtD
Phenelzine—Paraesthesia—Doxorubicin—sarcoma	0.000218	0.00212	CcSEcCtD
Phenelzine—Feeling abnormal—Epirubicin—sarcoma	0.000217	0.0021	CcSEcCtD
Phenelzine—Somnolence—Doxorubicin—sarcoma	0.000216	0.0021	CcSEcCtD
Phenelzine—Dyspepsia—Doxorubicin—sarcoma	0.000214	0.00208	CcSEcCtD
Phenelzine—Gastrointestinal disorder—Doxorubicin—sarcoma	0.00021	0.00204	CcSEcCtD
Phenelzine—Fatigue—Doxorubicin—sarcoma	0.00021	0.00203	CcSEcCtD
Phenelzine—Constipation—Doxorubicin—sarcoma	0.000208	0.00202	CcSEcCtD
Phenelzine—Body temperature increased—Epirubicin—sarcoma	0.000208	0.00202	CcSEcCtD
Phenelzine—Feeling abnormal—Doxorubicin—sarcoma	0.0002	0.00194	CcSEcCtD
Phenelzine—Body temperature increased—Doxorubicin—sarcoma	0.000192	0.00187	CcSEcCtD
Phenelzine—Asthenia—Epirubicin—sarcoma	0.000189	0.00183	CcSEcCtD
Phenelzine—Pruritus—Epirubicin—sarcoma	0.000186	0.0018	CcSEcCtD
Phenelzine—Asthenia—Doxorubicin—sarcoma	0.000174	0.00169	CcSEcCtD
Phenelzine—Dizziness—Epirubicin—sarcoma	0.000174	0.00169	CcSEcCtD
Phenelzine—Pruritus—Doxorubicin—sarcoma	0.000172	0.00167	CcSEcCtD
Phenelzine—Vomiting—Epirubicin—sarcoma	0.000167	0.00162	CcSEcCtD
Phenelzine—Rash—Epirubicin—sarcoma	0.000166	0.00161	CcSEcCtD
Phenelzine—Dermatitis—Epirubicin—sarcoma	0.000166	0.00161	CcSEcCtD
Phenelzine—Headache—Epirubicin—sarcoma	0.000165	0.0016	CcSEcCtD
Phenelzine—Dizziness—Doxorubicin—sarcoma	0.000161	0.00156	CcSEcCtD
Phenelzine—Nausea—Epirubicin—sarcoma	0.000156	0.00152	CcSEcCtD
Phenelzine—Vomiting—Doxorubicin—sarcoma	0.000155	0.0015	CcSEcCtD
Phenelzine—Rash—Doxorubicin—sarcoma	0.000153	0.00149	CcSEcCtD
Phenelzine—Dermatitis—Doxorubicin—sarcoma	0.000153	0.00149	CcSEcCtD
Phenelzine—Headache—Doxorubicin—sarcoma	0.000152	0.00148	CcSEcCtD
Phenelzine—Nausea—Doxorubicin—sarcoma	0.000144	0.0014	CcSEcCtD
